Why Bot Detection Has to Stop Chasing Signatures and Start Reading Intent 
Fireflies Expands Beyond Meeting Intelligence and Launches Daily Briefs to Help People Prioritize Work Across Meetings, Email, and Slack Addex mGlu2 NAM Cognition Program Receives €4 Million Grant
Addex led consortium wins Eurostars grant to deliver clinical candidates to treat mild neurocognitive disorders…
Lexus Presents the Theme of Diversification and Electrification Aiming to Deliver New Value to Customers
TOKYO, Sep 20, 2023 – (JCN Newswire) – Lexus International President Takashi Watanabe x Lexus…
Bravowhale Technology facilitate taicang local supply chain enterprises in achieving ESG compliance with international standards
Hong Kong, Sept 20, 2023 – (ACN Newswire) – Recently, the “‘Carbon’ Road Green Development…
Netcracker Strengthens Partnership With Google Cloud to Advance Generative AI in Telecom
Netcracker Integrates Its GenAI Telco Solution With Google Cloud’s Vertex AI to Increase Generative AI…
Clearfield Blows Past Traditional MPO Limits with FieldShield® Blowable MPO Fibre Assemblies
Industry-first pushable/blowable 12-fibre MPO pre-connectorized cable, field-tested at 1.5 KM, delivers ideal solution for any…
Space Programme Backed by Egyptian Businessman Set to Launch Most Powerful UK Reusable Rocket – Karman Space Programme
LONDON–(BUSINESS WIRE)–#Rocket– A university space programme from London are preparing to launch the most powerful British…
Yubico is Now Trading as YUBICO on Nasdaq in Stockholm
SANTA CLARA, Calif. & STOCKHOLM–(BUSINESS WIRE)–#2FA—Yubico, the leading provider of hardware authentication security keys, announced…
FDA Issues Complete Response Letter for neffy® (epinephrine nasal spray) New Drug Application with Request for Additional Study
Company aligned with FDA in August 2023 on both physician labeling and post-market requirements, which…
Bioventus to Present at the Cantor Global Healthcare Conference
DURHAM, N.C., Sept. 19, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS), a global leader…
R.T. Weatherman Foundation Unveils Dynamic Rebrand and New Website, Deepening Commitment to Global Democracy and Aid
KYIV, UKRAINE / ACN Newswire / September 20, 2023 / Recognized as the “last mile…
Moody’s Launches VIS Rating in Partnership with Vietnam’s Leading Financial institutions
NEW YORK–(BUSINESS WIRE)–Moody’s Corporation (NYSE:MCO) today announced the launch of Vietnam Investors Service And Credit…
HilleVax Announces Pricing of Public Offering of Common Stock
BOSTON, Sept. 19, 2023 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company…
Afterparty Secures $5M in Funding to Debut Afterparty AI; Enables Creators to Infinitely Scale Fan Interactions
LOS ANGELES–(BUSINESS WIRE)–Afterparty, the platform empowering thousands of creators with the tools and technology for…
USISPF, ReNew and the Consulate General of India Bring Together Business and Government Leaders to Discuss U.S.- India Climate Partnership
NEW YORK–(BUSINESS WIRE)–$RNW #ClimatePartnership–The US-India Strategic Partnership Forum (USISPF), and ReNew, in partnership with the…
Columbia Sportswear Company Releases 2022 Impact Report
PORTLAND, Ore.–(BUSINESS WIRE)–Columbia Sportswear Company (NASDAQ: COLM) (the “Company”), a global leading innovator in outdoor, active…
Nanobiotix to Announce Half Year 2023 Financial Results on September 26, 2023
Conference Call and Webcast to be Held at 8:00 AM EDT / 2:00 PM CEST…
Nanobiotix to Announce Half Year 2023 Financial Results on September 26, 2023
Conference Call and Webcast to be Held at 8:00 AM EDT / 2:00 PM CEST…
HilleVax Announces Proposed Public Offering of Common Stock
BOSTON, Sept. 19, 2023 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company…
HilleVax Announces Proposed Public Offering of Common Stock
BOSTON, Sept. 19, 2023 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company…
Eagle Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023
WOODCLIFF LAKE, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”…